Premature Ovarian Failure Cure Market, Global Outlook and Forecast 2022-2028

May 2022 | 67 pages | ID: P3ED814F3AB4EN
Market Monitor Global

Abstracts

Premature ovarian failure (POF, also called primary ovarian insufficiency or early menopause) is a common gynecological endocrine disease characterized by the loss of ovarian function in women below 40 years. Most often, it is a non-reversible pathology leading to infertility. Normally, ovaries produce hormones and eggs until the early fifties, when they stop working and most women enter menopause. However, phenomena such as the dysfunction and the depletion of follicles (the cellular aggregates in the ovaries secreting hormones that influence the menstrual cycle) lead to POF, whose prevalence is 1/250 in women under 35 years and 1/100 in women under 40 years; the consequent loss of ovarian reserve (the number of follicles remaining in a woman’s ovaries) increases the risk of infertility, severely affecting women both physically and mentally.

This report contains market size and forecasts of Premature Ovarian Failure Cure in Global, including the following market information:

Global Premature Ovarian Failure Cure Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Premature Ovarian Failure Cure market was valued at 900.2 million in 2021 and is projected to reach US$ 1473.4 million by 2028, at a CAGR of 7.3% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormone Replacement Therapy (HRT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Premature Ovarian Failure Cure include Pfizer, Bayer, Novartis, Bioscience Institute, Johns Hopkins Medicine, Mayo Clinic, Baptist Health and Indira IVF, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Premature Ovarian Failure Cure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Premature Ovarian Failure Cure Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Premature Ovarian Failure Cure Market Segment Percentages, by Type, 2021 (%)

• Hormone Replacement Therapy (HRT)
• Calcium and Vitamin D Supplements
• In Vitro Fertilization (IVF)
• Stem Cell Therapy
• Others

Global Premature Ovarian Failure Cure Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Premature Ovarian Failure Cure Market Segment Percentages, by Application, 2021 (%)

• Less than 20 Years Old
• 20 to 30 Years Old
• 30 to 45 Years Old
• 45 Years Old and Older

Global Premature Ovarian Failure Cure Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Premature Ovarian Failure Cure Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Premature Ovarian Failure Cure revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Premature Ovarian Failure Cure revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Bayer
• Novartis
• Bioscience Institute
• Johns Hopkins Medicine
• Mayo Clinic
• Baptist Health
• Indira IVF

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Premature Ovarian Failure Cure Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Premature Ovarian Failure Cure Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PREMATURE OVARIAN FAILURE CURE OVERALL MARKET SIZE

2.1 Global Premature Ovarian Failure Cure Market Size: 2021 VS 2028
2.2 Global Premature Ovarian Failure Cure Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Premature Ovarian Failure Cure Players in Global Market
3.2 Top Global Premature Ovarian Failure Cure Companies Ranked by Revenue
3.3 Global Premature Ovarian Failure Cure Revenue by Companies
3.4 Top 3 and Top 5 Premature Ovarian Failure Cure Companies in Global Market, by Revenue in 2021
3.5 Global Companies Premature Ovarian Failure Cure Product Type
3.6 Tier 1, Tier 2 and Tier 3 Premature Ovarian Failure Cure Players in Global Market
  3.6.1 List of Global Tier 1 Premature Ovarian Failure Cure Companies
  3.6.2 List of Global Tier 2 and Tier 3 Premature Ovarian Failure Cure Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Premature Ovarian Failure Cure Market Size Markets, 2021 & 2028
  4.1.2 Hormone Replacement Therapy (HRT)
  4.1.3 Calcium and Vitamin D Supplements
  4.1.4 In Vitro Fertilization (IVF)
  4.1.5 Stem Cell Therapy
  4.1.6 Others
4.2 By Type - Global Premature Ovarian Failure Cure Revenue & Forecasts
  4.2.1 By Type - Global Premature Ovarian Failure Cure Revenue, 2017-2022
  4.2.2 By Type - Global Premature Ovarian Failure Cure Revenue, 2023-2028
  4.2.3 By Type - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Premature Ovarian Failure Cure Market Size, 2021 & 2028
  5.1.2 Less than 20 Years Old
  5.1.3 20 to 30 Years Old
  5.1.4 30 to 45 Years Old
  5.1.5 45 Years Old and Older
5.2 By Application - Global Premature Ovarian Failure Cure Revenue & Forecasts
  5.2.1 By Application - Global Premature Ovarian Failure Cure Revenue, 2017-2022
  5.2.2 By Application - Global Premature Ovarian Failure Cure Revenue, 2023-2028
  5.2.3 By Application - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Premature Ovarian Failure Cure Market Size, 2021 & 2028
6.2 By Region - Global Premature Ovarian Failure Cure Revenue & Forecasts
  6.2.1 By Region - Global Premature Ovarian Failure Cure Revenue, 2017-2022
  6.2.2 By Region - Global Premature Ovarian Failure Cure Revenue, 2023-2028
  6.2.3 By Region - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Premature Ovarian Failure Cure Revenue, 2017-2028
  6.3.2 US Premature Ovarian Failure Cure Market Size, 2017-2028
  6.3.3 Canada Premature Ovarian Failure Cure Market Size, 2017-2028
  6.3.4 Mexico Premature Ovarian Failure Cure Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Premature Ovarian Failure Cure Revenue, 2017-2028
  6.4.2 Germany Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.3 France Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.4 U.K. Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.5 Italy Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.6 Russia Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.7 Nordic Countries Premature Ovarian Failure Cure Market Size, 2017-2028
  6.4.8 Benelux Premature Ovarian Failure Cure Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Premature Ovarian Failure Cure Revenue, 2017-2028
  6.5.2 China Premature Ovarian Failure Cure Market Size, 2017-2028
  6.5.3 Japan Premature Ovarian Failure Cure Market Size, 2017-2028
  6.5.4 South Korea Premature Ovarian Failure Cure Market Size, 2017-2028
  6.5.5 Southeast Asia Premature Ovarian Failure Cure Market Size, 2017-2028
  6.5.6 India Premature Ovarian Failure Cure Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Premature Ovarian Failure Cure Revenue, 2017-2028
  6.6.2 Brazil Premature Ovarian Failure Cure Market Size, 2017-2028
  6.6.3 Argentina Premature Ovarian Failure Cure Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Premature Ovarian Failure Cure Revenue, 2017-2028
  6.7.2 Turkey Premature Ovarian Failure Cure Market Size, 2017-2028
  6.7.3 Israel Premature Ovarian Failure Cure Market Size, 2017-2028
  6.7.4 Saudi Arabia Premature Ovarian Failure Cure Market Size, 2017-2028
  6.7.5 UAE Premature Ovarian Failure Cure Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Premature Ovarian Failure Cure Major Product Offerings
  7.1.4 Pfizer Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Premature Ovarian Failure Cure Major Product Offerings
  7.2.4 Bayer Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Premature Ovarian Failure Cure Major Product Offerings
  7.3.4 Novartis Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bioscience Institute
  7.4.1 Bioscience Institute Corporate Summary
  7.4.2 Bioscience Institute Business Overview
  7.4.3 Bioscience Institute Premature Ovarian Failure Cure Major Product Offerings
  7.4.4 Bioscience Institute Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.4.5 Bioscience Institute Key News
7.5 Johns Hopkins Medicine
  7.5.1 Johns Hopkins Medicine Corporate Summary
  7.5.2 Johns Hopkins Medicine Business Overview
  7.5.3 Johns Hopkins Medicine Premature Ovarian Failure Cure Major Product Offerings
  7.5.4 Johns Hopkins Medicine Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.5.5 Johns Hopkins Medicine Key News
7.6 Mayo Clinic
  7.6.1 Mayo Clinic Corporate Summary
  7.6.2 Mayo Clinic Business Overview
  7.6.3 Mayo Clinic Premature Ovarian Failure Cure Major Product Offerings
  7.6.4 Mayo Clinic Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.6.5 Mayo Clinic Key News
7.7 Baptist Health
  7.7.1 Baptist Health Corporate Summary
  7.7.2 Baptist Health Business Overview
  7.7.3 Baptist Health Premature Ovarian Failure Cure Major Product Offerings
  7.7.4 Baptist Health Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.7.5 Baptist Health Key News
7.8 Indira IVF
  7.8.1 Indira IVF Corporate Summary
  7.8.2 Indira IVF Business Overview
  7.8.3 Indira IVF Premature Ovarian Failure Cure Major Product Offerings
  7.8.4 Indira IVF Premature Ovarian Failure Cure Revenue in Global Market (2017-2022)
  7.8.5 Indira IVF Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Premature Ovarian Failure Cure Market Opportunities & Trends in Global Market
Table 2. Premature Ovarian Failure Cure Market Drivers in Global Market
Table 3. Premature Ovarian Failure Cure Market Restraints in Global Market
Table 4. Key Players of Premature Ovarian Failure Cure in Global Market
Table 5. Top Premature Ovarian Failure Cure Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Premature Ovarian Failure Cure Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Premature Ovarian Failure Cure Revenue Share by Companies, 2017-2022
Table 8. Global Companies Premature Ovarian Failure Cure Product Type
Table 9. List of Global Tier 1 Premature Ovarian Failure Cure Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Premature Ovarian Failure Cure Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Premature Ovarian Failure Cure Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Premature Ovarian Failure Cure Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Premature Ovarian Failure Cure Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Premature Ovarian Failure Cure Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Premature Ovarian Failure Cure Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Premature Ovarian Failure Cure Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Premature Ovarian Failure Cure Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Premature Ovarian Failure Cure Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Premature Ovarian Failure Cure Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Premature Ovarian Failure Cure Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Premature Ovarian Failure Cure Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Premature Ovarian Failure Cure Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Premature Ovarian Failure Cure Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Premature Ovarian Failure Cure Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Premature Ovarian Failure Cure Product Offerings
Table 32. Pfizer Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Premature Ovarian Failure Cure Product Offerings
Table 35. Bayer Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Premature Ovarian Failure Cure Product Offerings
Table 38. Novartis Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 39. Bioscience Institute Corporate Summary
Table 40. Bioscience Institute Premature Ovarian Failure Cure Product Offerings
Table 41. Bioscience Institute Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 42. Johns Hopkins Medicine Corporate Summary
Table 43. Johns Hopkins Medicine Premature Ovarian Failure Cure Product Offerings
Table 44. Johns Hopkins Medicine Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 45. Mayo Clinic Corporate Summary
Table 46. Mayo Clinic Premature Ovarian Failure Cure Product Offerings
Table 47. Mayo Clinic Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 48. Baptist Health Corporate Summary
Table 49. Baptist Health Premature Ovarian Failure Cure Product Offerings
Table 50. Baptist Health Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)
Table 51. Indira IVF Corporate Summary
Table 52. Indira IVF Premature Ovarian Failure Cure Product Offerings
Table 53. Indira IVF Premature Ovarian Failure Cure Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Premature Ovarian Failure Cure Segment by Type in 2021
Figure 2. Premature Ovarian Failure Cure Segment by Application in 2021
Figure 3. Global Premature Ovarian Failure Cure Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Premature Ovarian Failure Cure Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Premature Ovarian Failure Cure Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Premature Ovarian Failure Cure Revenue in 2021
Figure 8. By Type - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 9. By Application - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 10. By Region - Global Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 11. By Country - North America Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 12. US Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 16. Germany Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 17. France Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 24. China Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 28. India Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 30. Brazil Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Premature Ovarian Failure Cure Revenue Market Share, 2017-2028
Figure 33. Turkey Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Premature Ovarian Failure Cure Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bioscience Institute Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johns Hopkins Medicine Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mayo Clinic Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Baptist Health Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Indira IVF Premature Ovarian Failure Cure Revenue Year Over Year Growth (US$, Mn) & (2017-2022)